12582 Federal Register / Vol. 62, No. 51 / Monday, March 17, 1997 / Proposed Rules

regulatory action as defined by the

Executive Order and so is not subject to

review under the Executive Order.

The Regulatory Flexibility Act

requires agencies to analyze regulatory

options that would minimize any

significant impact of a rule on small

entities. The agency is proposing only to

provide firms with a timeframe in

which they can expect health claim

final rules to issue. Thus, in accordance

with the Regulatory Flexibility Act, the

agency certifies that this proposed rule

will not have a significant economic

impact on a substantial number of small

entities. Therefore, under the Regulatory

Flexibility Act, no further analysis is

required.

B. Environmental Impact

The agency has determined under 21

CFR 25.24(a)(8) that this action is of a

type that does not individually or

cumulatively have a significant effect on

the human environment. Therefore,

neither an environmental assessment

nor an environmental impact statement

is required.

IV. Paperwork Reduction Act

FDA tentatively concludes that this

proposed rule contains no reporting

recordkeeping, labeling, or other third

party disclosure requirements. Thus

there are no ‘‘information collection’’

requirements necessitating clearance by

OMB. However, to ensure the accuracy

of this tentative conclusion, FDA is

seeking comment on whether this

proposed rule imposes any paperwork

burden.

V. Effective Date

FDA is proposing to make the

amendment to § 101.70, contained

herein, effective 30 days after the

publication of a final rule that may issue

based on this proposal.

VI. Comments

Interested persons may, on or before

April 16, 1997, submit to the Docket

Management Branch (address above)

written comments regarding this

proposal. FDA is limiting the comment

period to 30 days because it is necessary

to do so if the agency is to comply with

the District Court’s order of January 31,

1997, that it establish a timeframe for

issuance of final rules on health claims

within 90 days of that order. FDA could

not publish a final rule within that

timeframe if it permitted the normal 75-

day comment period.

Two copies of any comments are to be

submitted, except that individuals may

submit one copy. Comments are to be

identified with the docket number

found in brackets in the heading of this

document. Received comments my be

seen in the Dockets Management Branch

between 9 a.m. and 4 p.m., Monday

through Friday.

List of Subjects in 21 CFR Part 101

Food Labeling, Nutrition, Reporting

and recordkeeping requirements.

Therefore, under the Federal Food,

Drug, and Cosmetic Act and under

authority delegated to the Commissioner

of Food and Drugs, it is proposed that

21 CFR part 101 be amended as follows:

PART 101—FOOD LABELING

1. The authority citation for 21 CFR

part 101 continues to read as follows:

Authority: Secs. 4, 5, 6 of the Fair

Packaging and Labeling Act (15 U.S.C. 1453,

1454, 1455); secs. 201, 301, 402, 403, 409,

501, 502, 505, 701 of the Federal Food, Drug,

and Cosmetic Act (21 U.S.C. 321, 331, 342,

343, 348, 351, 352, 355, 371).

2. Section 101.70 is amended by

adding new paragraph (j)(4) to read as

follows:

§ 101.70 Petitions for health claims.

* * * * *

(j) * * *

(4)(i) Within 270 days of the date of

publication of the proposal, FDA will

publish a final rule that either

authorizes use of the health claim or

explains why the agency has decided

not to authorize one.

(ii) For cause, FDA may extend the

period in which it will publish a final

rule. FDA will publish notice of the

extension in the Federal Register. The

document will explain the basis for the

extension, the length of the extension,

and the date by which the final rule will

be published.

Dated: March 4, 1997.

William B. Schultz,

Deputy Commissioner for Policy.

[FR Doc. 97–6710 Filed 3–13–97; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF THE TREASURY

Internal Revenue Service

26 CFR Parts 1 and 301

[REG–208172–91]

RIN 1545–AU71

Basis Reduction Due to Discharge of

Indebtedness; Hearing

AGENCY: Internal Revenue Service,

Treasury.

ACTION: Proposed rule; change of date

and location of public hearing.

SUMMARY: This document changes the

date and location of the public hearing

on the notice of proposed rulemaking

relating to basis reduction due to

discharge of indebtedness under

sections 108 and 1017 of the Internal

Revenue Code of 1986.

DATES: The public hearing is being held

on Thursday, May 29, 1997, beginning

at 10 a.m. Requests to speak and

outlines of oral comments must be

received by April 3, 1997.

ADDRESSES: The public hearing

originally scheduled in the IRS

Auditorium, Internal Revenue Building,

1111 Constitution Avenue, NW.,

Washington, DC is changed to the

Commissioner’s Conference Room, room

3313, Internal Revenue Building, 1111

Constitution Avenue, NW., Washington,

DC.

FOR FURTHER INFORMATION CONTACT:

Evangelista Lee of the Regulations Unit,

Assistant Chief Counsel (Corporate),

(202) 622–7180 (not a toll-free number).

SUPPLEMENTARY INFORMATION: A notice

of proposed rulemaking and notice of

public hearing appearing in the Federal

Register on Tuesday, January 7, 1997,

(62 FR 955) announced that a public

hearing on proposed regulations relating

to the basis reduction due to discharge

of indebtedness under sections 108 and

1017 would be held on Thursday, April

24, 1997, beginning at 10 a.m. in the IRS

Auditorium, Internal Revenue Building,

1111 Constitution Avenue, NW.,

Washington, DC and that requests to

speak and outlines of oral comments

should be received by Thursday, April

3, 1997.

The date and location of the public

hearing has changed. The hearing is

scheduled for Thursday, May 29, 1997,

beginning at 10 a.m. in the

Commissioner’s Conference Room, room

3313, Internal Revenue Building, 1111

Constitution Avenue, NW., Washington,

DC. We must receive requests to speak

and outlines of oral comments by

Thursday, April 3, 1997. Because of the

controlled access restrictions, attenders

are not admitted beyond the lobby of the

Internal Revenue Building until 9:45

a.m.

The Service will prepare an agenda

showing the scheduling of the speakers

after the outlines are received from the

persons testifying and make copies

available free of charge at the hearing.

Cynthia E. Grigsby,

Chief, Regulations Unit, Assistant Chief

Counsel (Corporate).

[FR Doc. 97–6674 Filed 3–14–97; 8:45 am]

BILLING CODE 4830–01–U